Literature DB >> 21347694

[Psychotherapy for obsessive-compulsive disorder: what is evidence based?].

A K Külz1, U Voderholzer.   

Abstract

Obsessive-compulsive disorder is a severe, very disabling condition that usually takes a chronic course if no adequate treatment is applied. Up to now, cognitive behavioural therapy with exposure and response prevention (CBT) is the most thoroughly investigated and most effective intervention, leading to a clinically significant symptom reduction in 60-70% of the patients. Correctly applied, this treatment can be equally effective as its combination with pharmacological management. For a correct implementation, however, several points have to be considered which are described in the following review. Considering the fact that some of the patients are unable to benefit sufficiently from this approach, potential alternatives and extensions of CBT are discussed. To date, however, no other treatment approach has proven to be effective based on randomised controlled trials.

Entities:  

Mesh:

Year:  2011        PMID: 21347694     DOI: 10.1007/s00115-010-2962-3

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  18 in total

1.  Barriers to treatment and service utilization in an internet sample of individuals with obsessive-compulsive symptoms.

Authors:  Luana Marques; Nicole J LeBlanc; Hilary M Weingarden; Kiara R Timpano; Michael Jenike; Sabine Wilhelm
Journal:  Depress Anxiety       Date:  2010-05       Impact factor: 6.505

2.  Development of a patient adherence scale for exposure and response prevention therapy.

Authors:  Helen Blair Simpson; Michael Maher; Jessica R Page; Carly J Gibbons; Martin E Franklin; Edna B Foa
Journal:  Behav Ther       Date:  2009-05-29

3.  Obsessive-compulsive disorder is uncommon but associated with high levels of comorbid neuroses, impaired function and increased suicidal acts in people in the UK.

Authors:  Paul Martin Salkovskis
Journal:  Evid Based Ment Health       Date:  2007-08

4.  Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial.

Authors:  Michael Rufer; Iver Hand; Heike Alsleben; Anne Braatz; Jürgen Ortmann; Birgit Katenkamp; Susanne Fricke; Helmut Peter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

5.  Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.

Authors:  Patricia van Oppen; Anton J L M van Balkom; Johannes H Smit; Josien Schuurmans; Richard van Dyck; Paul M G Emmelkamp
Journal:  J Clin Psychiatry       Date:  2010-03-23       Impact factor: 4.384

6.  Cognitive therapy for autogenous and reactive obsessions: clinical and cognitive outcomes at post-treatment and 1-year follow-up.

Authors:  Amparo Belloch; Elena Cabedo; Carmen Carrió; Christina Larsson
Journal:  J Anxiety Disord       Date:  2010-04-02

Review 7.  Group cognitive behavioural therapy for obsessive-compulsive disorder: a systematic review and meta-analysis.

Authors:  H Jónsson; E Hougaard
Journal:  Acta Psychiatr Scand       Date:  2008-09-23       Impact factor: 6.392

8.  An open trial of group metacognitive therapy for obsessive-compulsive disorder.

Authors:  Clare S Rees; Kate E van Koesveld
Journal:  J Behav Ther Exp Psychiatry       Date:  2008-01-18

9.  Psychological treatment of obsessive-compulsive disorder: a meta-analysis.

Authors:  Ana I Rosa-Alcázar; Julio Sánchez-Meca; Antonia Gómez-Conesa; Fulgencio Marín-Martínez
Journal:  Clin Psychol Rev       Date:  2008-07-04

10.  The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder.

Authors:  Roseli Gedanke Shavitt; Carolina Valério; Victor Fossaluza; Elizabeth Meyer da Silva; Quirino Cordeiro; Juliana Belo Diniz; Cristina Belotto-Silva; Aristides Volpato Cordioli; Jair Mari; Eurípedes Constantino Miguel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-03       Impact factor: 5.270

View more
  3 in total

1.  Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial.

Authors:  Anne Katrin Külz; Sarah Landmann; Barbara Cludius; Birgit Hottenrott; Nina Rose; Thomas Heidenreich; Elisabeth Hertenstein; Ulrich Voderholzer; Steffen Moritz
Journal:  BMC Psychiatry       Date:  2014-11-18       Impact factor: 3.630

2.  Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors.

Authors:  Frederike Schirmbeck; Mathias Zink
Journal:  Front Pharmacol       Date:  2013-08-09       Impact factor: 5.810

Review 3.  Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment.

Authors:  Mathias Zink
Journal:  Adv Med       Date:  2014-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.